Free Trial
NYSE:EHAB

Enhabit (EHAB) Stock Price, News & Analysis

Enhabit logo
$7.98 +0.42 (+5.49%)
As of 03:20 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Enhabit Stock (NYSE:EHAB)

Key Stats

Today's Range
$7.59
$7.98
50-Day Range
$6.53
$10.76
52-Week Range
$6.47
$10.90
Volume
240,496 shs
Average Volume
454,326 shs
Market Capitalization
$404.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.67
Consensus Rating
Hold

Company Overview

Enhabit Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

EHAB MarketRank™: 

Enhabit scored higher than 38% of companies evaluated by MarketBeat, and ranked 659th out of 1,876 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Enhabit has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Enhabit has only been the subject of 1 research reports in the past 90 days.

  • Read more about Enhabit's stock forecast and price target.
  • Earnings Growth

    Earnings for Enhabit are expected to grow by 31.82% in the coming year, from $0.22 to $0.29 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Enhabit is -2.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Enhabit is -2.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Enhabit has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Enhabit's valuation and earnings.
  • Percentage of Shares Shorted

    3.48% of the float of Enhabit has been sold short.
  • Short Interest Ratio / Days to Cover

    Enhabit has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Enhabit has recently increased by 10.14%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Enhabit does not currently pay a dividend.

  • Dividend Growth

    Enhabit does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.48% of the float of Enhabit has been sold short.
  • Short Interest Ratio / Days to Cover

    Enhabit has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Enhabit has recently increased by 10.14%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Enhabit has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Enhabit this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for EHAB on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Enhabit insiders have bought more of their company's stock than they have sold. Specifically, they have bought $76,400.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 3.40% of the stock of Enhabit is held by insiders.

  • Read more about Enhabit's insider trading history.
Receive EHAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enhabit and its competitors with MarketBeat's FREE daily newsletter.

EHAB Stock News Headlines

Trump’s SHOCKING Plan to Create MASSIVE Wealth for Americans
James Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presidential decision in modern history. According to his research, this could set off a massive wealth wave—potentially turning a $900 investment into $108,000 in under a year. It has nothing to do with tariffs or trade wars—but it’s already gaining momentum, and the window to act is closing fast.
Enhabit, Inc. (EHAB) Q2 2025 Earnings Call Transcript
Enhabit (EHAB) Q2 EPS Jumps 86%
See More Headlines

EHAB Stock Analysis - Frequently Asked Questions

Enhabit's stock was trading at $7.81 on January 1st, 2025. Since then, EHAB stock has increased by 1.7% and is now trading at $7.9450.

Enhabit, Inc. (NYSE:EHAB) announced its quarterly earnings data on Wednesday, August, 6th. The company reported $0.13 earnings per share for the quarter, topping analysts' consensus estimates of $0.10 by $0.03. The company had revenue of $266.10 million for the quarter, compared to analyst estimates of $263.39 million. Enhabit had a positive trailing twelve-month return on equity of 2.72% and a negative net margin of 12.84%.
Read the conference call transcript
.

Top institutional investors of Enhabit include 8 Knots Management LLC (7.60%), AREX Capital Management LP (4.90%), Systematic Financial Management LP (3.83%) and Paradice Investment Management LLC (3.43%). Insiders that own company stock include Ryan Solomon, Jeffrey Bolton, Stuart M Mcguigan, Ronald Leroy Langham Jr, L Edward Shaw Jr, Erin Hoeflinger, Gregory S Rush and Collin Mcquiddy.
View institutional ownership trends
.

Shares of EHAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enhabit investors own include Alphabet (GOOG), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), Netflix (NFLX), Home Depot (HD) and Meta Platforms (META).

Company Calendar

Last Earnings
8/06/2025
Today
8/18/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NYSE:EHAB
CIK
1803737
Fax
N/A
Employees
10,700
Year Founded
N/A

Price Target and Rating

High Price Target
$9.50
Low Price Target
$8.00
Potential Upside/Downside
+11.0%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.67)
Trailing P/E Ratio
N/A
Forward P/E Ratio
35.50
P/E Growth
N/A
Net Income
-$156.20 million
Net Margins
-12.84%
Pretax Margin
-12.17%
Return on Equity
2.72%
Return on Assets
1.25%

Debt

Debt-to-Equity Ratio
0.79
Current Ratio
1.57
Quick Ratio
1.57

Sales & Book Value

Annual Sales
$1.03 billion
Price / Sales
0.38
Cash Flow
$4.22 per share
Price / Cash Flow
1.85
Book Value
$10.92 per share
Price / Book
0.72

Miscellaneous

Outstanding Shares
50,690,000
Free Float
48,967,000
Market Cap
$395.89 million
Optionable
Optionable
Beta
1.68
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:EHAB) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners